Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Guardion Health Sciences, Inc. (GHSI)

7.58   0.96 (14.5%) 01-27 15:59
Open: 6.48 Pre. Close: 6.62
High: 7.63 Low: 6.48
Volume: 40,145 Market Cap: 9(M)

Technical analysis

as of: 2023-01-27 4:44:52 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 9.7     One year: 11.33
Support: Support1: 6.75    Support2: 5.8
Resistance: Resistance1: 8.31    Resistance2: 9.7
Pivot: 7.11
Moving Average: MA(5): 6.76     MA(20): 7.14
MA(100): 7.77     MA(250): 9.15
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 46.7     %D(3): 36.2
RSI: RSI(14): 53.2
52-week: High: 31.5  Low: 0.14
Average Vol(K): 3-Month: 25 (K)  10-Days: 22 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GHSI ] has closed below upper band by 31.2%. Bollinger Bands are 26.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.64 - 7.67 7.67 - 7.71
Low: 6.4 - 6.44 6.44 - 6.47
Close: 7.51 - 7.58 7.58 - 7.64

Company Description

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Headline News

Wed, 25 Jan 2023
Guardion Health Sciences regains compliance with Nasdaq - Seeking Alpha

Tue, 24 Jan 2023
2023-01-24 | NDAQ:GHSI | Press Release | Guardion Health ... - Stockhouse

Fri, 20 Jan 2023
Indian streaming company Lytus Technologies stock soars as high ... - Seeking Alpha

Tue, 17 Jan 2023
DHIS2 Configuration Expert & Project Liaison - Nigeria - ReliefWeb

Mon, 09 Jan 2023
Is Guardion Health Sciences (GHSI) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver

Fri, 06 Jan 2023
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023 - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 62 (M)
Shares Float 56 (M)
% Held by Insiders 9.5 (%)
% Held by Institutions 7.7 (%)
Shares Short 5,430 (K)
Shares Short P.Month 5,570 (K)

Stock Financials

EPS -0.88
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.43
Profit Margin (%) -187.6
Operating Margin (%) -79.6
Return on Assets (ttm) -16.3
Return on Equity (ttm) -65.1
Qtrly Rev. Growth -15.4
Gross Profit (p.s.) 0.05
Sales Per Share 0.17
EBITDA (p.s.) -0.13
Qtrly Earnings Growth 0
Operating Cash Flow -8 (M)
Levered Free Cash Flow -4 (M)

Stock Valuations

PE Ratio -8.64
PEG Ratio 0
Price to Book value 17.62
Price to Sales 42.64
Price to Cash Flow -61.04

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.